About The Study: In this cohort study of patients infected with COVID-19, patients with serious mental illness (schizophrenia, bipolar disorder, or recurrent major depressive disorder) compared with those without serious mental illness were at increased risk of postacute sequelae of SARS-CoV-2 (PASC), underscoring the need for coordinated mental health and COVID-19 care strategies. PASC is defined as ongoing, relapsing, or new symptoms or other health effects occurring after the acute phase of SARS-CoV-2 infection (i.e., that present 4 weeks or more after the acute infection).
Corresponding Author: To contact the corresponding author, Jyotishman Pathak, PhD, email jyp2001@med.cornell.edu .
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.40242)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.40242?guestAccessKey=1b34668e-afe8-4888-aa3d-dd05b3b83eff&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=102925
JAMA Network Open